Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernadette Johnson

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
EJNMMI Research|January 5, 2012
18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)Gary Cook, Chris Parker, Sue Chua, et al.
BJU International|June 8, 2007
The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumoursRamachandran Venkitaraman, Bernadette Johnson, Robert A Huddart, et al.
AIDS and Behavior|April 21, 2022
PrEP service delivery preferences of black Cis-gender women living in the Southern United StatesLatesha Elopre, Alexander Boutwell, Bretia Gordon, et al.
Archives of Sexual Behavior|January 10, 2024
"Just the Stigma Associated with PrEP Makes You Feel Like It's HIV Itself": Exploring PrEP Stigma, Skepticism, and Medical Mistrust Among Black Cisgender Women in Urban and Rural Counties in the U.S. Deep SouthWhitney C Irie, Anais Mahone, Bernadette Johnson, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
JMIR Research Protocols|March 14, 2025
Improving Pre-Exposure Prophylaxis Provision as Part of Routine Gynecologic Care Among Black Cisgender Women (Project PrEP4Her): Protocol for the Implementation of an InterventionMaira Sohail, Lynn Matthews, Audra Williams, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2015
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal MetastasesSarah J Chittenden, Cecilia Hindorf, Christopher C Parker, et al.
Sexually Transmitted Diseases|August 29, 2023
Factors Associated With Willingness to Use Preexposure Prophylaxis Among Black Cisgender Women Residing in Rural and Urban Areas: A Cross-Sectional StudyMaira Sohail, Alexander Boutwell, Bernadette Johnson, et al.
Applied Clinical Informatics|November 3, 2016
Usability and Workflow Evaluation of "RhEumAtic Disease activitY" (READY). A Mobile Application for Rheumatology Patients and ProvidersPo-Yin Yen, Barbara Lara, Marcelo Lopetegui, et al.
The British Journal of Radiology|January 3, 2018
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapyAna M Denis-Bacelar, Sarah J Chittenden, V Ralph McCready, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
EJNMMI Research|January 5, 2012
18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)Gary Cook, Chris Parker, Sue Chua, et al.
BJU International|June 8, 2007
The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumoursRamachandran Venkitaraman, Bernadette Johnson, Robert A Huddart, et al.
AIDS and Behavior|April 21, 2022
PrEP service delivery preferences of black Cis-gender women living in the Southern United StatesLatesha Elopre, Alexander Boutwell, Bretia Gordon, et al.
Archives of Sexual Behavior|January 10, 2024
"Just the Stigma Associated with PrEP Makes You Feel Like It's HIV Itself": Exploring PrEP Stigma, Skepticism, and Medical Mistrust Among Black Cisgender Women in Urban and Rural Counties in the U.S. Deep SouthWhitney C Irie, Anais Mahone, Bernadette Johnson, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
JMIR Research Protocols|March 14, 2025
Improving Pre-Exposure Prophylaxis Provision as Part of Routine Gynecologic Care Among Black Cisgender Women (Project PrEP4Her): Protocol for the Implementation of an InterventionMaira Sohail, Lynn Matthews, Audra Williams, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2015
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal MetastasesSarah J Chittenden, Cecilia Hindorf, Christopher C Parker, et al.
Sexually Transmitted Diseases|August 29, 2023
Factors Associated With Willingness to Use Preexposure Prophylaxis Among Black Cisgender Women Residing in Rural and Urban Areas: A Cross-Sectional StudyMaira Sohail, Alexander Boutwell, Bernadette Johnson, et al.
Applied Clinical Informatics|November 3, 2016
Usability and Workflow Evaluation of "RhEumAtic Disease activitY" (READY). A Mobile Application for Rheumatology Patients and ProvidersPo-Yin Yen, Barbara Lara, Marcelo Lopetegui, et al.
The British Journal of Radiology|January 3, 2018
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapyAna M Denis-Bacelar, Sarah J Chittenden, V Ralph McCready, et al.
Pageof 5